H-CYTE, Inc. Aktie - Unternehmensdaten & Kurse - US4041241096 | goSPATZ

H-CYTE, Inc.

Share · US4041241096 (OTC)

No Price

n/a

Company Profile for H-CYTE, Inc. Share

H-CYTE, Inc., a biopharmaceutical company, develops and delivers various treatments for patients with chronic respiratory and pulmonary disorders in the United States. The company develops and implements treatment options in autologous cellular therapy to treat chronic lung disorders. It has a product supply agreement with Rion, LLC to develop and distribute a biologic for chronic obstructive pulmonary disease. The company is headquartered in Tampa, Florida.

Get up to date insights from finAgent about H-CYTE, Inc.

Company Data

Name H-CYTE, Inc.

Company H-CYTE, Inc.

Website https://www.hcyte.com

Primary Exchange

UTC

ISIN US4041241096

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Michael W. Yurkowsky

Country United States of America

Currency USD

Employees 0,0 T

Address 2202 North West Shore Boulevard, 33607 Tampa

IPO Date 2014-12-19

ID Changes

Date	From	To
16.07.2019	MDVX	HCYT

Ticker Symbols

Name	Symbol
Over The Counter	HCYT

More Shares

Investors who hold H-CYTE, Inc. also have the following shares in their portfolio:

ALLREAL HLDG 21/30 Bond

ISHARES MSCI EASTERN EUROPE CAPPED UCITS ETF USD (DIST) ETF

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog

Im App Store herunterladen

Bei Google Play herunterladen

All rights reserved © LCP GmbH 2025